Selective serotonin reuptake inhibitor fluoxetine, reduces solid tumor burden and metastasis through activation of host antitumor immune response and modulation of tumor microenvironment
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Cancer
Stress
Anesthesia
and Immune Response
Immune cells in cancer
Publication details
- Journal / source
- Journal of Pharmacology and Experimental Therapeutics
- Volume
- 393
- Issue
- 3
- Pages
- 103810–103810
- Publication date
- 31 January 2026
- Language
- EN